High-dose β-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients

Circulation

Volumn 114, Issue SUPPL. 1, 2006, Pages

  Feringa, Harm H H ^a   Bax, Jeroen J ^b   Boersma, Eric ^d   Kertai, Miklos D ^a   Meij, Simon H ^a   Galal, Wael ^a   Schouten, Olaf ^a   Thomson, Ian R ^c   Klootwijk, Peter ^a   Van Sambeek, Marc R H M ^a   Klein, Jan ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MANITOBA   (Canada)

^d University of Rotterdam ^*

Author keywords

Beta blockers; Heart rate; Ischemia; Surgery

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; LABETALOL; METOPROLOL; PROPRANOLOL DERIVATIVE; TROPONIN T; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; TREATMENT OUTCOME; VASCULAR SURGERY; BLOOD; DOSE RESPONSE; DRUG EFFECT; ELECTIVE SURGERY; EVALUATION; MIDDLE AGED; MONITORING; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; RISK; STATISTICS; STRESS ECHOCARDIOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL ISCHEMIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RISK; SURGICAL PROCEDURES, ELECTIVE; TROPONIN T; VASCULAR SURGICAL PROCEDURES;

EID: 33747161065     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.000463     Document Type: Article

References (17)

1. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789-1794.
2. The Study of Perioperative Ischemia Research Group. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing non-cardiac surgery. N Engl J Med. 1990;323:1781-1788.
3. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major non-cardiac surgery. N Engl J Med. 2005;353:349-361.
4. ACC/AHA guideline update for perioperative cardiovascular evaluation for non-cardiac surgery - executive summary a report of the Am College of Cardiology/Am Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Non-cardiac Surgery). Circulation. 2002;105:1257-1267.
5. Task Force on B-blockers of the European Society of Cardiology. Expert consensus document on β-adrenergic receptor blockers. Eur Heart J. 2004;25:1341-1362.
6. Cruickshank JM. Beta-blockers continue to surprise us. Eur Heart J. 2000;21:354-364.
7. Auerbach AD, Goldman L. Beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA. 2002;287:1435-1444.
8. Devereaux PJ, Beattie WS, Choi PT, Badner NH, Guyatt GH, Villar JC, Cina CS, Leslie K, Jacka MJ, Montori VM, Bhandari M, Avezum A, Cavalcanti AB, Giles JW, Schricker T, Yang H, Jakobsen CJ, Yusuf S. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331:313-321.
9. U.S. Food and Drug Administration. Maximum Recommended Therapeutic Dose Database. Available from: http://www.fda.gov/cder/Offices/OPS_IO/MRTD.htm.
10. Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the Am Society of Echocardiography. J Am Soc Echocardiogr. 1998;11:97-104.
11. McSPI Research Group. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology. 1998;88:7-17.
12. Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, Whittemore AD. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 1999;88:477-482.
13. Lopez-Jimenez F, Goldman L, Sacks DB, Thomas EJ, Johnson PA, Cook EF, Lee TH. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J Am Coll Cardiol. 1997;29:1241-1245.
14. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.
15. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-2804.
16. Yeager MP, Fillinger MP, Hettleman BD, Hartman GS. Perioperative beta-blockade and late cardiac outcomes: a complementary hypothesis. J Cardiothorac Vasc Anesth. 2005;19:237-241.
17. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation. 2001;104:1477-1482.